AFP and hepatocellular carcinoma: However, the performance of AFP as a diagnostic biomarker for HCC is controversial because of its unsatisfactory specificity and sensitivity, and the efficacy of AFP in prognostic prediction is influenced by cut-off criteria [10, 11].